Simon Cottle

Simon Cottle is a founding partner at Stanley Capital, where a research and technology-based approach focuses on sustainable investment sectors, particularly Resource Efficiency and Healthcare. Cottle also serves as an investor and board director at Roboyo, an independent consultancy specializing in AI-powered automation technologies, and as an investor in Laboratoire XO, a pharmaceutical company. In addition to these roles, Cottle holds positions as a board member at Cognition and HeidiPay, and invests in various companies including OpenDialog AI, Qinecsa Solutions, Fintecture, and Essential Pharma. Cottle's educational background includes an MBA from INSEAD and a Master's from the University of Oxford, complemented by a top academic scholarship at Shrewsbury School.